New injection for high cholesterol begins first human safety tests
NCT ID NCT07241923
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 1 trial is testing a new injection called SYH2070 in 48 healthy adults to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and measure blood fat levels. This is an early step to see if the drug might one day help lower high triglycerides and cholesterol.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SYH2070 injection
- What this could lead to
- If this early study shows the drug is safe, it could lead to larger trials testing whether SYH2070 can lower high triglycerides and cholesterol.
- What could go wrong
- This is a very early, small phase 1 trial in healthy people, not patients. The drug may not work or could have side effects. Many drugs fail at this stage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Trials Information Group
RECRUITINGShijiazhuang, Hebei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A two-session balance workout may cut fall risk in seniors
- Salty air: a new way to help lungs sweep themselves clean?
- First human test of SSGJ-626: will it be safe?
- Scientists to test how healthy bodies react to exercise in thin air
- Does stretching after weights change how your heart recovers?
- Could heart disease start outside the heart? new imaging study aims to find out